Filing Details

Accession Number:
0001140361-21-038872
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-22 16:01:42
Reporting Period:
2021-11-18
Accepted Time:
2021-11-22 16:01:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1228627 Ocuphire Pharma Inc. OCUP Pharmaceutical Preparations (2834) 113516358
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236365 J S James Manuso C/O Ocuphire Pharma, Inc.
37000 Grand River Ave, Suite 120
Farmington Hills MI 48335
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-18 2,000 $3.50 16,570 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price represents the weighted average price of the multiple transactions reported on this line. The shares were purchased at prices ranging from $3.4966 to $3.4998. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.